awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38741042-3A845EBD-BE20-4DDF-8F7B-5A668C584A6D
Q38741042-3A845EBD-BE20-4DDF-8F7B-5A668C584A6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38741042-3A845EBD-BE20-4DDF-8F7B-5A668C584A6D
Targeted therapy in esophageal cancer.
P2860
Q38741042-3A845EBD-BE20-4DDF-8F7B-5A668C584A6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38741042-3A845EBD-BE20-4DDF-8F7B-5A668C584A6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
05d955251ae596e980e3d25a6e7714c26e522994
P2860
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction